These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of statins on endothelium and signaling mechanisms. Endres M; Laufs U Stroke; 2004 Nov; 35(11 Suppl 1):2708-11. PubMed ID: 15375300 [TBL] [Abstract][Full Text] [Related]
7. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells. Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111 [TBL] [Abstract][Full Text] [Related]
8. Statin treatment and 3' polyadenylation of eNOS mRNA. Kosmidou I; Moore JP; Weber M; Searles CD Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2642-9. PubMed ID: 17916773 [TBL] [Abstract][Full Text] [Related]
9. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Trebicka J; Hennenberg M; Laleman W; Shelest N; Biecker E; Schepke M; Nevens F; Sauerbruch T; Heller J Hepatology; 2007 Jul; 46(1):242-53. PubMed ID: 17596891 [TBL] [Abstract][Full Text] [Related]
10. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho]. Sawada N; Itoh H; Nakao K Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357 [TBL] [Abstract][Full Text] [Related]
11. Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Laufs U Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978 [TBL] [Abstract][Full Text] [Related]
13. Antioxidative effects of statins. Adam O; Laufs U Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762 [TBL] [Abstract][Full Text] [Related]
14. Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide. Ma S; Ma CC Vascul Pharmacol; 2014 Nov; 63(2):63-70. PubMed ID: 25139660 [TBL] [Abstract][Full Text] [Related]
15. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. Sawada N; Liao JK Antioxid Redox Signal; 2014 Mar; 20(8):1251-67. PubMed ID: 23919640 [TBL] [Abstract][Full Text] [Related]
16. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery. Shiga N; Hirano K; Hirano M; Nishimura J; Nawata H; Kanaide H Circ Res; 2005 May; 96(9):1014-21. PubMed ID: 15817883 [TBL] [Abstract][Full Text] [Related]
17. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy. Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257 [TBL] [Abstract][Full Text] [Related]
18. Statins, nitric oxide and neovascularization. Ma FX; Han ZC Cardiovasc Drug Rev; 2005; 23(4):281-92. PubMed ID: 16614729 [TBL] [Abstract][Full Text] [Related]
19. Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC. Takeuchi S; Kawashima S; Rikitake Y; Ueyama T; Inoue N; Hirata K; Yokoyama M Biochem Biophys Res Commun; 2000 Mar; 269(1):97-102. PubMed ID: 10694484 [TBL] [Abstract][Full Text] [Related]
20. Pleiotropic effects of statins. Liao JK; Laufs U Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]